• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同源二聚体细胞因子受体的激活机制及致癌突变的失调。

Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.

机构信息

Department of Biology and Center of Cellular Nanoanalytics, University of Osnabrück, 49076 Osnabrück, Germany.

Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK.

出版信息

Science. 2020 Feb 7;367(6478):643-652. doi: 10.1126/science.aaw3242.

DOI:10.1126/science.aaw3242
PMID:32029621
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8117407/
Abstract

Homodimeric class I cytokine receptors are assumed to exist as preformed dimers that are activated by ligand-induced conformational changes. We quantified the dimerization of three prototypic class I cytokine receptors in the plasma membrane of living cells by single-molecule fluorescence microscopy. Spatial and spatiotemporal correlation of individual receptor subunits showed ligand-induced dimerization and revealed that the associated Janus kinase 2 (JAK2) dimerizes through its pseudokinase domain. Oncogenic receptor and hyperactive JAK2 mutants promoted ligand-independent dimerization, highlighting the formation of receptor dimers as the switch responsible for signal activation. Atomistic modeling and molecular dynamics simulations based on a detailed energetic analysis of the interactions involved in dimerization yielded a mechanistic blueprint for homodimeric class I cytokine receptor activation and its dysregulation by individual mutations.

摘要

同源二聚体 I 类细胞因子受体被认为以前体二聚体的形式存在,通过配体诱导的构象变化而被激活。我们通过单分子荧光显微镜定量测量了三种典型的 I 类细胞因子受体在活细胞质膜中的二聚化。单个受体亚基的空间和时空相关性显示出配体诱导的二聚化,并揭示了相关的 Janus 激酶 2(JAK2)通过其假激酶结构域二聚化。致癌受体和高活性 JAK2 突变体促进了配体非依赖性二聚化,突出了受体二聚体的形成作为负责信号激活的开关。基于对二聚化涉及的相互作用进行详细能量分析的原子建模和分子动力学模拟,为同源二聚体 I 类细胞因子受体的激活及其由单个突变引起的失调提供了一种机制蓝图。

相似文献

1
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.同源二聚体细胞因子受体的激活机制及致癌突变的失调。
Science. 2020 Feb 7;367(6478):643-652. doi: 10.1126/science.aaw3242.
2
Mechanism of activation of protein kinase JAK2 by the growth hormone receptor.生长激素受体激活蛋白激酶 JAK2 的机制。
Science. 2014 May 16;344(6185):1249783. doi: 10.1126/science.1249783.
3
Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signaling.JAK2 激活的分子基础:促红细胞生成素受体和致病性 JAK2 信号转导。
Sci Adv. 2024 Mar 8;10(10):eadl2097. doi: 10.1126/sciadv.adl2097.
4
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation.受体介导的 JAK2 FERM 结构域二聚化是 JAK2 激活所必需的。
Elife. 2018 Jul 25;7:e38089. doi: 10.7554/eLife.38089.
5
A JAK2 interdomain linker relays Epo receptor engagement signals to kinase activation.一个JAK2结构域间连接子将促红细胞生成素受体结合信号传递至激酶激活。
J Biol Chem. 2009 Sep 25;284(39):26988-98. doi: 10.1074/jbc.M109.011387. Epub 2009 Jul 28.
6
Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.促红细胞生成素受体在配体激活前形成二聚体的晶体学证据。
Science. 1999 Feb 12;283(5404):987-90. doi: 10.1126/science.283.5404.987.
7
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.通过计算建模从原子水平揭示临床相关 MPL 突变对跨膜结构域的影响。
PLoS One. 2011;6(8):e23396. doi: 10.1371/journal.pone.0023396. Epub 2011 Aug 17.
8
Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F.细胞因子受体介导的二聚化对于JAK2V617F的组成性激活是必需的。
J Biol Chem. 2008 Feb 29;283(9):5258-66. doi: 10.1074/jbc.M707125200. Epub 2007 Dec 23.
9
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes.JAK2 V617F 导致血小板生成素受体下调:病理性 JAK2 信号和蛋白酶体抑制剂可恢复受体水平。
Blood. 2012 May 17;119(20):4625-35. doi: 10.1182/blood-2011-08-372524. Epub 2012 Feb 29.
10
JAK2, the JAK2 V617F mutant and cytokine receptors.JAK2、JAK2 V617F突变体和细胞因子受体。
Pathol Biol (Paris). 2007 Mar;55(2):88-91. doi: 10.1016/j.patbio.2006.06.003. Epub 2006 Aug 14.

引用本文的文献

1
Real-time visualization of STAT activation in live cells using genetically encoded biosensors.使用基因编码生物传感器对活细胞中STAT激活进行实时可视化。
Nat Chem Biol. 2025 Sep 1. doi: 10.1038/s41589-025-02012-0.
2
Molecular Dynamics Simulation Analysis of JAK1 Initial Activation: Phosphorylation-Induced Conformational Dynamics and Domain Interactions.JAK1初始激活的分子动力学模拟分析:磷酸化诱导的构象动力学和结构域相互作用
Life (Basel). 2025 Aug 19;15(8):1316. doi: 10.3390/life15081316.
3
Single-molecule tweezers decode hidden dimerization patterns of membrane proteins within lipid bilayers.

本文引用的文献

1
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis.细胞因子受体信号的拓扑控制诱导造血中的差异效应。
Science. 2019 May 24;364(6442). doi: 10.1126/science.aav7532. Epub 2019 May 23.
2
Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutations.Janus 激酶 2 激活机制的揭示:抑制突变分析。
J Allergy Clin Immunol. 2019 Apr;143(4):1549-1559.e6. doi: 10.1016/j.jaci.2018.07.022. Epub 2018 Aug 6.
3
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation.
单分子镊子解码脂质双层中膜蛋白隐藏的二聚化模式。
Nat Commun. 2025 Aug 9;16(1):7366. doi: 10.1038/s41467-025-62852-1.
4
Structural basis of MPL activation by thrombopoietin.血小板生成素激活MPL的结构基础。
Blood Vessel Thromb Hemost. 2024 Jul 16;1(3):100018. doi: 10.1016/j.bvth.2024.100018. eCollection 2024 Sep.
5
Autophagosome-lysosome mediated secretion of the thrombopoietin receptor is modulated by distinct driver mutations of myeloproliferative neoplasm.自噬体-溶酶体介导的血小板生成素受体分泌受骨髓增殖性肿瘤不同驱动突变的调节。
Leukemia. 2025 Jul 3. doi: 10.1038/s41375-025-02676-6.
6
Malignant JAK-signaling: at the interface of inflammation and malignant transformation.恶性JAK信号传导:炎症与恶性转化的交汇点
Leukemia. 2025 May;39(5):1011-1030. doi: 10.1038/s41375-025-02569-8. Epub 2025 Mar 26.
7
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives.骨髓纤维化的靶向治疗:现状、正在进行的研究及未来展望
Am J Hematol. 2025 Jun;100 Suppl 4(Suppl 4):30-50. doi: 10.1002/ajh.27658. Epub 2025 Mar 10.
8
Effective in vivo binding energy landscape illustrates kinetic stability of RBPJ-DNA binding.有效的体内结合能景观说明了RBPJ-DNA结合的动力学稳定性。
Nat Commun. 2025 Feb 1;16(1):1259. doi: 10.1038/s41467-025-56515-4.
9
Recent Advancements in Imaging Techniques for Individual Extracellular Vesicles.个体细胞外囊泡成像技术的最新进展
Molecules. 2024 Dec 10;29(24):5828. doi: 10.3390/molecules29245828.
10
Neutrophil diversity and function in health and disease.中性粒细胞在健康与疾病中的多样性及功能。
Signal Transduct Target Ther. 2024 Dec 6;9(1):343. doi: 10.1038/s41392-024-02049-y.
受体介导的 JAK2 FERM 结构域二聚化是 JAK2 激活所必需的。
Elife. 2018 Jul 25;7:e38089. doi: 10.7554/eLife.38089.
4
The regulation of JAKs in cytokine signaling and its breakdown in disease.JAK 家族在细胞因子信号转导中的调节及其在疾病中的失调。
Cytokine. 2019 Jun;118:48-63. doi: 10.1016/j.cyto.2018.03.041. Epub 2018 May 21.
5
Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase.JAK2酪氨酸激酶调控的机制性见解
Front Endocrinol (Lausanne). 2018 Jan 5;8:361. doi: 10.3389/fendo.2017.00361. eCollection 2017.
6
Molecular insights into regulation of JAK2 in myeloproliferative neoplasms.骨髓增殖性肿瘤中JAK2调控的分子见解
Blood. 2015 May 28;125(22):3388-92. doi: 10.1182/blood-2015-01-621110. Epub 2015 Mar 30.
7
Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands.通过用替代配体重新定向二聚体几何结构来调节细胞因子受体信号传导。
Cell. 2015 Mar 12;160(6):1196-208. doi: 10.1016/j.cell.2015.02.011. Epub 2015 Feb 26.
8
JAK2 activation by growth hormone and other cytokines.生长激素和其他细胞因子对JAK2的激活作用。
Biochem J. 2015 Feb 15;466(1):1-11. doi: 10.1042/BJ20141293.
9
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.依赖于假激酶的 JAK2 酪氨酸激酶自身抑制的分子基础。
Nat Struct Mol Biol. 2014 Jul;21(7):579-84. doi: 10.1038/nsmb.2849. Epub 2014 Jun 11.
10
g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations.g_mmpbsa——一种用于高通量MM-PBSA计算的GROMACS工具。
J Chem Inf Model. 2014 Jul 28;54(7):1951-62. doi: 10.1021/ci500020m. Epub 2014 Jun 19.